Research Interests:
  • Nutritional Assessment
  • Body Composition
  • Energy Metabolism
  • Sarcopenic Obesity, Sarcopenia, Obesity, Cachexia
  • Clinical Nutrition
  • Cancer
  • Aging
 Dr. Prado is interested in the study of nutritional assessment and status. Most of her research has focused on investigating the prevalence of abnormal body composition and its relationship to health outcomes in different cohorts of patients.  Her expertise also includes the assessment of whole-body macronutrient metabolism and the regulation of body weight and composition. Her lab is dedicated to the study of nutrient intake, energy metabolism and skeletal muscle and adipose tissue dynamics and its effect on health. Her lab is particularly interested in studying the relationship between muscle loss, obesity and interacting body composition changes among different susceptible groups.
Current Grant Funding:
  • Alberta Innovates
  • Almased®
  • Canadian Cancer Society
  • Canadian Foundation for Dietetic Research
  • Canadian Foundation for Innovation
  • Canadian Institutes of Health Research – Canada
  • Cancer Strategic Clinical Network
  • Diabetes, Obesity, & Nutrition Strategic Clinical Network
  • National Institutes of Health – USA
  • Women and Children's Health Research Institute Innovation Grant 
 Collaborative Grant Funding (as co-investigator/collaborator):
  • Arthritis Society Strategic
  • Natural Science and Engineering Research Council of Canada
  • Susan G. Komen Foundation
  • Weston Family Microbiome Initiative
Peer-Reviewed Publications:
  1. Purcell SA, Baracos VA, Chu QSC, Sawyer MB, Severin D, Mourtzakis M, Lieffers J, Prado CM. Profiling determinants of resting energy expenditure in colorectal cancer. Nutrition and Cancer. 2019 Jul 8:1-8. doi: 10.1080/01635581.2019.1635172. [Epub ahead of print]
  2. Purcell SA, Elliott SA, Baracos VE, Chu QSC, Sawyer MB, Mourtzakis M, Easaw JC, Spratlin JL, Siervo M, Prado CM. Accuracy of resting energy expenditure predictive equations in patients with cancer. Nutrition in Clinical Practice. 2019 Jul 25. doi: 10.1002/ncp.10374. [Epub ahead of print]
  3. Zambrano DN, Xiao J, Prado CM, Gonzalez MC. J. Patient-generated subjective global assessment and computed tomography in the assessment of malnutrition and sarcopenia in patients with cirrhosis: is there any association? Clinical Nutrition. 2019 Jun 27. pii: S0261-5614(19)30274-2. doi: 10.1016/j.clnu.2019.06.018. [Epub ahead of print]
  4. Ryan AM, Prado CM, Sullivan ES, Power DG, Daly LE. Effects of weight loss and sarcopenia on response to chemotherapy, quality of life and survival. Nutrition. 2019 Jun 28;67-68:110539. doi: 10.1016/j.nut.2019.06.020. [Epub ahead of print]
  5. Sheean P, Gonzalez MC, Prado CM, McKeever L, Hall AM, Braunschweig CA. American Society of Parenteral and Enteral Nutrition Clinical Guidelines: the Validity of Body Composition Assessment in Clinical Populations. JPEN J Parenter Enteral Nutr. 2019 Jun 19. doi: 10.1002/jpen.1669. [Epub ahead of print] 
  6. Rees JL, Chang CR, François ME, Marcotte-Chénard A, Fontvieille A, Klaprat ND, Dyck RA, Funk DR, Snydmiller G, Bastell K, Godkin FE, Dubé MC, Riesco E, McGavock JM; Yardley JE; Sigal RJ, Gibala MJ, Weisnagel J, Prado CM, Jung M, Manders R, Lee T, Singer J, Boule NM, Little JP. Minimal effect of walking before dinner on glycemic responses in type 2 diabetes: Outcomes from the multi-site E-PAraDiGM Study. Acta Diabetologica. 2019 Jul;56(7):755-765. doi: 10.1007/s00592-019-01358-x.
  7. Purcell SA, Elliott SA, Walter PJ, Preston T, Cai H, Skipworth RJS, Sawyer MB, Prado CM. Total energy expenditure in patients with colorectal cancer: Associations with body composition, physical activity, and energy recommendations. Am J Clin Nutrition. 2019 Aug 1;110(2):367-376. doi: 10.1093/ajcn/nqz112.
  8. Godziuk C, Prado CM, Woodhouse LJ, Forhan M. Prevalence of sarcopenic obesity in adults with end-stage knee osteoarthritis. Osteoarthritis and Cartilage . 2019 Jul 2. pii: S1063-4584(19)31109-4. doi: 10.1016/j.joca.2019.05.026. [Epub ahead of print]
  9. Orsso CE, Tibaes JRB, Oliveira CLP, Rubin DA, Field C, Heymsfield SB, Prado CM, Haqq AM. Low muscle mass and strength in pediatrics patients: why should we care? Clinical Nutrition. 2019 Oct;38(5):2002-2015. doi: 10.1016/j.clnu.2019.04.012
  10. Brown J, Caan BJ, Prado CM, Cespedes Feliciano EM, Xiao J, Kroenke CH, Meyerhardt JA. Body Composition and Cardiovascular Events in Patients with Colorectal Cancer: A Population-Based Retrospective Cohort Study (C-SCANS). JAMA Oncology. 2019 Jul 1;5(7):967-972. doi: 10.1001/jamaoncol.2019.0695.
  11. Bradshaw P. Cespedes Feliciano EM, Prado CM, Alexeeff S, Albers KB, Chen WY, Caan BJ. Adipose tissue distribution and survival among women with non-metastatic breast cancer. Accepted: Obesity
  12. Debroy P, Lake JE, Sim M, Erlandson KM, Falutz J, Prado CM, Silva AR, Brown TT, Guaraldi G for the Modena HIV Metabolic Cohort Team. Lean mass declines consistently over 10 years in people living with HIV on antiretroviral therapy, with patterns differing by sex. Antiviral Therapy. 2019 Apr 29. doi: 10.3851/IMP3312. [Epub ahead of print]
  13. Prado CM, Purcell SA, Alish C, Pereira SL, Deutz NE, Heyland DK, Goodpaster BH,. Tappenden KA, Heymsfield SB. Implications of low muscle mass across the continuum of care: a narrative review. Annals of Medicine. 2018 Dec;50(8):675-693. doi: 10.1080/07853890.2018.1511918.
  14. Xiao J, Caan BJ, PhD1, Cespedes Feliciano E, Meyerhardt JE, Kroenke CH, Baracos VE, Weltzien E, Kwan MJ, Alexeeff SE, Castillo AL, Prado CM. The association of medical and demographic characteristics with sarcopenia and low muscle radiodensity in patients with nonmetastatic colorectal cancer. American Journal of Clinical Nutrition. 2019 Mar 1;109(3):615-625. doi: 10.1093/ajcn/nqy328
  15. Pereira LC, Elliott SA, J McCargar, Bell RC, Vu K, Robson PJ, Prado CM. The influence of energy metabolism on postpartum weight retention. American Journal of Clinical Nutrition. 2019 Jun 1;109(6):1588-1599. doi: 10.1093/ajcn/nqy389.
  16. Pereira LC, Purcell SA, Elliott SA, J McCargar, Bell RC, Robson PJ, Prado CM. The use of whole body calorimetry to compare measured versus predicted energy expenditure in postpartum women. American Journal of Clinical Nutrition. 2019 Mar 1;109(3):554-565. doi: 10.1093/ajcn/nqy312
  17. Deutz NEP, Ashurst I, Ballesteros MD, Bear DE, Cruz-Jentoff AJ, Genton L, Landi F, Laviano A, Norman K, Prado CM. The underappreciated role of low muscle mass in the management of malnutrition. JAMDA: The Journal of post-acute and long-term care medicine. 2019 Jan;20(1):22-27. doi: 10.1016/j.jamda.2018.11.021.
  18. Purcell SA, Wallengren O, Baracos VE, Lundholm K, IresjöBM, Chu QS, Ghosh SS, Prado CM. Determinants of change in resting energy expenditure in patients with stage III/IV colorectal cancer. Clinical Nutrition. 2019 Mar 30. pii: S0261-5614(19)30135-9. doi: 10.1016/j.clnu.2018.12.038. [Epub ahead of print]
  19. Brown A, Prado CM, Ghosh S, Leonard S, Arciero P, Tucker K, Orsmbee M. Higher-protein intake and physical activity are associated with healthier body composition and cardiometabolic health in Hispanic adults. Clinical Nutrition ESPEN.2019 Apr;30:145-151. doi: 10.1016/j.clnesp.2019.01.002.
  20. Van Aller C, Lara J, Stephan B, Donini LM, Heymsfield S, Katzmarzyk P, Wells J, Prado CM, Siervo S. Sarcopenic obesity and overall mortality: results from the application of novel models of body composition phenotypes to the National Health and Nutrition Examination Survey 1999-2004. Clinical Nutrition. 2019 Feb;38(1):264-270. doi: 10.1016/j.clnu.2018.01.022.
  21. Purcell SA, Xiao J, Ford KL, Prado CM. The role of energy balance on colorectal cancer survival. Current Colorectal Cancer Reports. 2018 14(6): 266-273.
  22. Oliveira CLP, Dionne IJ, Prado CM. Are Canadian protein and physical activity guidelines optimal for sarcopenia prevention in older adults? Applied Physiology, Nutrition, and Metabolism, 2018 Dec;43(12):1215-1223. doi: 10.1139/apnm-2018-0141
  23. Maurício SF, Generoso SV, Vieira ELM, Xiao J, Prado CM, Gonzalez MC, Correia MITD. Relationship between sarcopenia and mTOR pathway in patients with colorectal cancer: Preliminary Report. Nutrition and Cancer. 2019;71(1):172-177. doi: 10.1080/01635581.2018.1540716
  24. Debroy P, Sim, M, Erlandson K, Falutz J, Prado CM, Brown T, Guaraldi G, Lake J. Progressive Increases in Fat Mass Occur in Adults Living with HIV on Antiretroviral Therapy, but Patterns Differ by Sex and Anatomic Depot. Journal of Antimicrobial Chemotherapy. 2019 Apr 1;74(4):1028-1034. doi: 10.1093/jac/dky551.
  25. Orsso CE, ButlerAA, Muehlbauer MJ, Cui HN, Rubin DA, Pakseresht M, Butler MG, Prado CM, Freemark M, Haqq AM. Obestatin and adropin in Prader-Willi syndrome and non-syndromic obesity: associations with weight, BMI-z, and HOMA-IR. Pediatric Obesity. 2019 May;14(5):e12493. doi: 10.1111/ijpo.12493.
  26. Mota JF, Walter J, Prado CM. Insights into the relationship between gut microbiota and colorectal cancer. Current Colorectal Cancer Reports. 2018 14(6): 251-265. 
  27. Elliott SA, Pereira LCR, McCargar LJ, Prado CM, Bell RC; ENRICH Study Team.  Trajectory and determinants of change in lean soft tissue over the postpartum period. British Journal Nutrition, May;121(10):1137-1145. doi: 10.1017/S0007114518002015.
  28. Pereira LC, Elliott SA, McCargar LJ, Bell RC, Prado CM. Changes in Energy Metabolism from Pre-pregnancy to Postpartum: A Case Report. Canadian Journal of Dietetic Practice and Research 2018 79(4):191-195.
  29. Purcell SA, Elliott SE, Ryan AM, Sawyer M, Prado CM. Accuracy of a Portable Indirect Calorimeter for Measuring Resting Energy Expenditure in Individuals with Cancer. Journal of Parenteral and Enteral Nutrition. Journal of Parenteral and Enteral Nutrition. 2019 Jan;43(1):145-151.
  30. Amy A. Kirkham, D. Ian Paterson, Carla M. Prado, John M. Mackey, Kerry S. Courneya, Edith Pituskin, and Richard B. Thompson. Rationale and design of the Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study: a 3-arm parallel group phase II randomized controlled trial in early breast cancer. BMC Cancer. 2018; 18: 864. Published online 2018 Sep 3. doi: 10.1186/s12885-018-4778-7.
  31. Mauricio SF, Generoso SV, Xiao J, Prado CM, Gonzalez MC, Correia MITD. Different nutritional assessment tools as predictors of postoperative complications in patients undergoing colorectal cancer resection. Clinical Nutrition. 2018 Oct;37(5):1505-1511.
  32. Xiao J, Caan BJ, Weltzien E, Cespedes EM, Kroenke CH, Meyerhardt JA, Baracos VE, Kwan ML, Castillo AL, Prado, CM. Associations of pre-existing co-morbidities with skeletal muscle mass and radiodensity in patients with non-metastatic colorectal cancer. Journal of Cachexia, Sarcopenia and Muscle. 2018 Aug;9(4):654-663.
  33. Brown JC, Caan BJ, Meyerhardt JA, Weltzien E, Xiao J, Cespedes Feliciano EM, Kroenke CH, Castillo A, Kwan ML, Prado CM. The Deterioration of Muscle Mass and Radiodensity is Prognostic of Poor Survival in Stage I-III Colorectal Cancer: A Population-Based Cohort Study (C-SCANS). Journal of Cachexia, Sarcopenia and Muscle. 2018 Aug;9(4):664-672.
  34. Kroenke CH, Prado CM, Meyerhardt JA, Weltzien EK, Xiao J, Cespedes Feliciano EM, Caan BJ. Muscle radiodensity and mortality in patients with colorectal cancer. Cancer. 2018 Jul 15;124(14):3008-3015.
  35. Danai LV, Babic A, Rosenthal MH, Dennstedt E, Muir A, Lien EC, Mayers JR, Tai K, Lau AN, Sali PJ, Prado CM, Petersen GM, Takahashi N, Sugimoto M, Yeh JJ, Lopez N, Bardeesy N, Castillo CF, Liss AS, Koong AC, Bui J, Yuan C, Welch MW, Brais LK, Kulke MH, Dennis C, Clish CB, Wolpin BM, Heiden MV. Altered exocrine function can drive adipose wasting in early pancreatic cancer. Nature. 2018 Jun;558(7711):600-604.
  36. Toledo DO, Carvalho AM, Oliveira AM,Toloi JM, Silva AC, Farah JF, Prado CM, Silva Jr JM. The Use of Computed Tomography Images as a Prognostic Marker in Critically Ill Cancer Patients. Clinical Nutrition ESPEN. 2018 Jun;25:114-120.
  37. Daily LE, Prado CM, Ryan AM. A window beneath the skin: how computed tomography assessment of body composition can assist in the identification of hidden wasting conditions in oncology that profoundly impact outcomes? Proceedings of the Nutrition Society. 2018 May;77(2):135-151.
  38. Johnson Stoklossa CA, Ghosh SS, Forhan M, Sharma AM, Terada RT, Siervo M, Baracos VE, Padwal RS, Hung PA, Sawyer MB, Maia YL, Prado CM. Poor physical function as a marker for sarcopenic obesity in adults with class II/III obesity. Current Developments in Nutrition. 2018; 2(3): nzx008,
  39. Xiao J, Cain A, Purcell SA, Ormsbee MJ, Contreras RJ, Kim JS, Thornberry R, Springs D, Gonzalez C, Prado CM. Sarcopenic obesity and health outcomes in patients seeking weight loss treatment. Clinical Nutrition ESPEN. 2018 Feb;23:79-83.
  40. Erlandson KE, Lake JE, Sim M, Falutz J, Prado CM, Domingues da Silva AN, Brown TT, Guaraldi G. Bone Mineral Density Declines Twice as Quickly Among HIV-Infected Women Compared to Men. Journal of Acquired Immune Deficiency Syndromes. 2018; 1; 77(3):288-294
  41. Jo E, Worts P, Elam M, Brown AF, Khamoui A, Kim D-H, Yeh MC, Ormsbee MJ, Prado CM, Cain A, Smith D, Snyder K, Kim JS. Resistance training during a 12-week protein supplemented VLCD treatment enhances weight-loss outcomes in obese patients. Clinical Nutrition. 2017 Dec 23. pii: S0261-5614(17)31435-8. doi: 10.1016/j.clnu.2017.12.015. [Epub ahead of print].
  42. Jo, E., Cain, A., Prado, C., Brown, A. F., Ormsbee, M. J., Snyder, K., & Kim, J-S. (2017). Age- and Sex-Related Differences on Very Low Calorie Treatment Outcomes in Obese Bariatric Patients. Californian Journal of Health Promotion, 15 (3); 25-36.
  43. Xiao J, Mazurak VC, Olobatuyi TA, Caan BJ, Prado CM. Visceral Adiposity and Cancer Survival: A Review of Imaging Studies. European Journal of Cancer Care. 2018 Mar;27(2):e12611.
  44. Xiao J, Purcell S, Prado CM, Gonzalez MC. Fat mass to fat-free mass ratio reference values from NHANES III using bioelectric impedance analysis. Clinical Nutrition. 2017 Oct 6. pii: S0261-5614(17)31353-5. doi: 10.1016/j.clnu.2017.09.021. [Epub ahead of print].
  45. Cespedes Feliciano EM, Lee VS, Prado CM, Meyerhardt J, Alexeeff S, Kroenke CH, Xiao J, Castillo AL, Caan BJ. Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study. Cancer. 2017; 123(24):4868-4877.
  46. Cespedes Feliciano EM, Kroenke CH, Meyerhardt JA, Prado CM, Bradshaw PT, Kwan MJ, Xiao J, Alexeed S, Corley D, Weltzien E, Castillo AL, Caan BJ. Association of systemic Inflammation and sarcopenia with survival in nometastatic colorectal cancer: results from the C-Scans study. JAMA Oncology. 2017; 3(12):e172319.
  47. Alsaif M, Elliott SA, MacKenzie ML, Prado CM, Field CJ, Haqq AM. Energy metabolism profile in individuals with Prader-Willi syndrome and implications for clinical management: a systematic review. Advances in Nutrition. 2017 Nov 15;8(6):905-915.
  48. Caan BJ, Meyerhardt JA, Prado CM. Explaining the obesity paradox-response. Cancer Epidemiol Biomarkers Prev. 2017;26(10):1576.
  49. Caan BJ, Meyerhadt JA, Kroenke CH, Alexeeff S, Xiao J, Weltzien E, Cespedes Feliciano EM, Castillo AL, Quesenberry CP, Kwan MK, Prado CM. Explaining the obesity paradox: the association between body composition and colorectal cancer survival. Cancer Epidemiology, Biomarkers & Prevention. 2017 26(7):1008-1015.
  50. Terada T, Boulé NG, Forhan M, Prado CM, Kenny GP, Prud’homme D, Ito E, Sigal RJ. Cardiometabolic risk factors in type 2 diabetes with high fat and low muscle mass: At baseline and in response to exercise. Obesity. 2017;25(5):881-891
  51. Orsso CE, Mackenzie M, Alberga A , Sharma AM, Richer L, Prado CM, Haqq AM. The use of magnetic resonance imaging to characterize abnormal body composition phenotypes in youth with Prader-Willi syndrome. Metabolism: clinical and experimental. 2017 Apr;69:67-75.
  52. Oliveira CLP, Mattingly S, Schirrmacher R, Sawyer MB, Fine EJ, Prado CM. A nutritional perspective of ketogenic diet in cancer: a narrative review. Journal of the Academy of Nutrition and Dietetics. 2017 Mar 30. pii: S2212-2672(17)30115-6.
  53. Johnson Stoklossa C, Sharma A, Forhan M, Siervo M, Padway R, Prado CM. Prevalence of sarcopenic obesity in adults with class II/III obesity using different diagnostic criteria. J Nutrition and Metabolism. 2017; Mar 22:7307618, doi:10.1155/2017/7307618.
  54. Elizabeth M. Cespedes, Candyce H. Kroenke, Patrick T. Bradshaw, Wendy Y. Chen, Carla M. Prado, Erin K. Weltzien, Adrienne L. Castillo, Bette J. Caan. Post-diagnosis Weight Change and Survival Following a Diagnosis of Early Stage Breast Cancer. Ahead of print: Cancer Epidemiology, Biomarkers and Prevention. 2017, 26 (1): 44-50
  55. Meyerhardt J, Kroenke CH, Prado CM, Kwan M, Castillo A, Weltzien E, Xiao J, Caan BJ. Association of Weight Change after Colorectal Cancer Diagnosis and Outcomes in the Kaiser Permanente Northern California Population. Cancer Epidemiology, Biomarkers and Prevention. 2017 Jan;26(1):30-37.
  56. Geisler C, Prado CM, Muller MJ. Inadequacy of body weight-based recommendations for individual protein and energy intake: lessons from body composition analysis. Nutrients 2016 Dec 31;9(1). pii: E23. doi: 10.3390/nu9010023.
  57. Kroenke CH, Caan BJ, Prado CM. The optimal body mass index range for patients with colorectal cancer – Reply.  JAMA Oncol. 2017 May 1;3(5):708. doi: 10.1001/jamaoncol.2016.5280.
  58. Powell M, Lara J, Mocciaro G, Prado CM, Battezzati A, Leone A, Tagliabue A, De Amicis R, Vignati L, Bertoli S, Siervo M. Association between ratio indexes of body composition phenotypes and metabolic risk in Italian adults. Clinical Obesity. 2016 Dec;6(6):365-375.
  59. Johnson Stoklossa C, Forhan M, Padwal RS, Gonzalez MC, Prado CM. Practical considerations for body composition assessment of adults with class II/III obesity using bioelectrical impedance analysis or dual-energy X-ray absorptiometry. Current Obesity Reports. 2016 Dec;5(4):389-396.
  60. Vishal D, Xiao J, Prado CM, Silva AC, Burroughs P, McGee D, Hurt JE, Mohamed SG, Noel T. Computed tomography-derived skeletal muscle index: A novel predictor of frailty and hospital length of stay after transcatheter aortic valve replacement. American Heart Journal. 2016 Dec;182:21-27.  
  61. Cespedes Feliciano EM, Kroenke CH, Meyerhadt JA, Prado CM, Weltzien E, Castillo A, Dannenberg A, Xiao J, Caan BJ. Metabolic Dysfunction, Obesity, and Survival Among Patients With Early-Stage Colorectal Cancer. Journal of Clinical Oncology. 2016 Oct;34(30) 3664-3671.
  62.  Carneiro IP, Mazurak VC, Prado CM. Clinical implication of sarcopenic obesity in cancer. Current Oncology Report. 2016 Oct;18(10):62. doi: 10.1007/s11912-016-0546-5.
  63. Heyland D, Stapleton R, Mourtzakis M, Hough T, Morris P, Deutz NE, Colantuoni E, Day A, Prado CM, Needham DM. Combining nutrition and exercise to optimize survival and recovery from critical illness: conceptual and methodological issues. Clin Nutrition. 2016 Oct;35(5):1196-206. 
  64. Kroenke CH, Neugebauer R, Meyerhardt J, Prado CM, Weltzien E, Kwan M, Xiao J, Caan BJ. Analysis of Body Mass Index and Mortality in Patients with Colorectal Cancer Using Causal Diagrams. JAMA Oncology. 2016 Sep 1;2(9):1137-45. doi:10.1001/jamaoncol.2016.0732.  
  65. Crawford J, Prado CM*, Johnston MA, Gralla RJ, Taylor RP, Hancock ML, Dalton, JT. Study Design and Rationale for the Phase 3 Clinical Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials). *Co-first Author. Current Oncology Reports: 2016 Jun;18(6):37. 
  66. Prado CM, Cushen S, Orsso C, Ryan A. Sarcopenia and Cachexia in the Era of Obesity: Clinical and Nutritional Impact. Proceeding of the Nutrition Society. 2016 May;75(2):188-98. 
  67. Ryan AM, Power DG, Daly L, Cushen SJ, Bhuachalla EN, Prado CM. Cancer-associated malnutrition, cachexia and sarcopenia: The skeleton in the hospital closed 40 years later. Proceeding of the Nutrition Society. 2016 May;75(2):199-211.
  68. Sawyer MB, Pituskin E, Sambasivarao D, Bies RR, Vos LJ, Prado CM, Kuzma M, Scarfe AG, Clemons M, Tonkin K, Au HJ, Koski S, Joy AA, Smylie M, King K, Carandand D, Damaraju VL, Hanson J, Cass CE, Mackey JR. A uridine glucuronosyltransferase 2B7 polymorphism predicts epirubicin clearance and outcomes in early stage breast cancer. Clinical Breast Cancer. 2016 Apr;16(2):139-144.e3 
  69. Purcell S, Elliott S, Baracos VE, Prado CM. Key Determinants of Energy Expenditure in Cancer and Implications for Clinical Practice. European Journal of Clinical Nutrition 2016,;70(11):1230-1238.
  70. Carneiro IP, Elliott SA, Siervo M, Padwal R, Bertoli S, Battezzati A. Prado CM. Is obesity associated with altered energy expenditure? Advances in Nutrition, 2016 v.7:476-487. 
  71. Cushen SJ, Power DG, Murphy KP, McDermott R, Griffin BT, Lim M, Daly L, Maceneaney P, O'Sullivan K, Prado CM, Ryan AM. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel. Clinical Nutrition ESPEN 2016, v.13: e-39-45.
  72. Jo Edward, Kim JS, Ormsbee MJ, Prado C, Khamoui AV. The Physiological Basis For Weight Recidivism Following Severe Caloric Restrictive Diet Therapies: A Molecular Rationale For Exercise-And Nutrition-Based Treatment Optimization. Journal of Advanced Nutrition and Human Metabolism. 2016; 2:e1105. doi: 10.14800/janhm.1105
  73. Purcell S, Elliott SA, Kroenke CH, Sawyer MB, Prado CM. Impact of Body Weight and Body Composition on Ovarian Cancer Prognosis. Current Oncology Reports, 2016 Feb;18(2):8.
  74. Purcell S, Thornberry R, Elliott SA, Panton L, Ormsbee MJ, Vieira ER, Kim J-S, Prado CM. Body composition, strength, and dietary intake of patients with hip or knee osteoarthritis. Canadian Journal of Dietetic Practice and Research. 2016, 77(2): 98-102.
  75. Montano-Loza AJ, Angulo P. Meza-Junco J, Prado CM, Sawyer MB, Beaumont C, Esfandiari N, Ma M, Baracos VE. Sarcopenic obesity and myosteratosis are associated with higher mortality in patients with cirrhosis. Journal of Cachexia, Sarcopenia and Muscle. 2016 v.7(2):126-135.
  76. Vieira ER, Mendy A, Prado CM, Gasana J, Albatineh A. Falls, physical limitations, confusion and memory problems in people with type II diabetes, undiagnosed diabetes and prediabetes, and the influence of vitamins A, D and E.  Journal of Diabetes and its Complications. 2015 Nov-Dec;29(8):1159-64. 
  77. Prado CM, Gonzalez MC, Heymsfield SB. Body composition and obesity paradox. Current Opinion in Clinical Nutrition and Metabolic Care. 2015. 18(6): 535-51. 
  78. Hall DK, Bemis T, Brychta R, Chen K, Courville A, Goodwin S, Guo J, Howard L, Knuth ND, Miller BV, Prado CM, Preuschl E, Siervo M, Skarulis M, Yannai L. Calorie for Calorie, Dietary Fat Restriction Results in More Body Fat Loss than Carbohydrate Restriction in People with Obesity. Cell Metabolism. 2015 22(3): 427-436. 
  79. Siervo M, Prado C*, Hooper L, Munro A, Collerton J, Davies K, Kingston A, Mathers JC, Kirkwood TB, Jagger C. Serum osmolarity and haematocrit do not modify the association between the impedance index (Ht(2)/Z) and total body water in the very old: The Newcastle 85+ Study. Archives of Gerontology and Geriatrics. 2015;60(1):227-32. *co-first author.
  80. Prado CM, Heymsfield S. Lean Tissue Imaging: A New Era for Nutritional Assessment and Intervention. Journal of Parenteral and Enteral Nutrition. 2014; 38(8):940-53.
  81. Siervo M, Prado CM, Mire E, Wells JCK, Heymsfield S, Katzmarzyk P. Body composition indexes of capacity model: gender and BMI-specific reference curves. Public Health Nutrition. 2014;18(7):1245-54.
  82. de Souza RGM, Gomes AC, Prado CMM, Mota JF. Métodos de análise da composição corporal em obesos. Revista de Nutrição. 2014; 27(5)”569-83. (Manuscript in Portuguese).
  83. de van der Schueren M, Elia M, Gramlich L, Johnson MP, Lim SL, Philipson T, Prado CM. Clinical and economic outcomes of nutrition interventions across the continuum of care. Annals of the New York Academy of Sciences. 2014;1321:20-4.
  84.  Siervo M, Bunn D, Prado CM, Hooper L. Accuracy of prediction equations for serum osmolarity in frail older people with and without diabetes. American Journal of Clinical Nutrition. 2014;100(3):867-76.
  85. Fogelman DR, Holmes H, Mohammed K, Katz MH, Prado CM, Lieffers J, Garg N, Varadhachary GR, Shroff R, Overman MJ, Garrett C, Wolff RA, Javle M. Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer? Journal of Cachexia, Sarcopenia and Muscle. 2014 Dec;5(4):307-13.
  86. Prado CM, Siervo M, Mire E, Heymsfield SB, Stephan BC, Broyles S, Smith SR, Wells JC, Katzmarzyk PT. A population-based approach to define body-composition phenotypes. The American Journal of Clinical Nutrition. 2014 Jun;99(6):1369-77.
  87. Ormsbee MJ, Prado CM, Ilich JZ, Purcell S, Siervo M, Folsom A, Panton L. Osteosarcopenic obesity: the role of bone, muscle, and fat on health. Journal of Cachexia, Sarcopenia and Muscle. 2014 Sep;5(3):183-92.  
  88. Montano-Loza AJ, Meza-Junco J, Baracos VE, Prado CM, Ma M, Tandon P, Meeberg G, Beaumont C, Esfandiari N, Sawyer MB, Kneteman N. Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation. Liver Transplantation. 2014;20(6):640-8.
  89. Prado CM, Baracos VE, Xiao J, Birdsell L, Stuyckens K, Park YC, Parekh T, Sawyer MB. The association between body composition and toxicities from the combination of Doxil and trabectedin inpatients with advanced relapsed ovarian cancer. Applied Physiology, Nutrition, and Metabolism. 2014;39(6):693-8.   
  90. Esfandiari N, Ghosh S, Prado CM, Martin L, Mazurak V, Baracos VE. Age, obesity, sarcopenia, proximity to death explain reduced mean muscle attenuation in patients with advanced cancer. Journal of Frailty and Aging. 2014;3(1):3-8.
  91. Siervo M, Prado CM, Stephan BC, Lara J, Muscariello E, Nasti G, Colantuoni A. Association of the body adiposity index (BAI) with metabolic risk factors in young and older overweight and obese womenEating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity. 2014;19(3):397-402.
  92. Prado CM, Sawyer MB, Ghosh S, Lieffers JR, Esfandiari N, Antoun S, Baracos V. The central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential? American Journal of Clinical Nutrition. 2013;98(4):1012-9.
  93. Prado CM. Body composition in chemotherapy: the promising role of CT scans. Current Opinion in Clinical Nutrition and Metabolic Care. 2013;16(5)525-33.
  94. Prado CM, Maia YLM, Ormsbee M, Sawyer M. Baracos VE. Assessment of nutritional status in cancer – the relationship between body composition and pharmacokinetics. Anti-Cancer Agents in Medicinal Chemistry. 2013;13(8):1197-203.
  95. Meza-Junco, Montano-Loza AJ,Baracos VE, Prado CM, Bain VG, Beaumont, C, Esfandiari N, Lieffers JR, Sawyer MB. Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma. Journal of Clinical Gastroenterology. 2013; 47(10):861-70. 
  96. Prado CM, Lieffers JR, Bowthorpe L, Baracos VE, Mourtzakis M, McCargar LJ. Sarcopenia and Physical Function in Overweight Patients with Advanced CancerCanadian Journal of Dietetic Practice and Research. 2013;74(2):69-74.
  97. Rock L, Milner JA, Prado C, Green R, Caan BJ, Hilakivi-Clarke L. Current nutritional issues in cancer treatment and survivorship. – American Institute for Cancer Research Extended Abstracts from 2011 Conference. Nutrition Today, 2013; 48(1): 33-34.
  98. Thoresen L, Frykholm G, Ludersen S, Ulveland H, Baracos V, Prado CM, Birdsell L, Falkmer U. Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results. Clinical Nutrition.2013;32(1):65-72.
  99. Prado CM, Wells JCK, Smith S, Stephan BCM, Siervo M. Sarcopenic Obesity: A Critical Appraisal of the Current Evidence. Clinical Nutrition. 2012;31(5):583-601.
  100. Siervo M, Nasti G, Stephan BCM, Papa A, Muscariello E, Wells JCK, Prado CM, Colantuoni A. Effects of intentional weight loss on physical and cognitive function in middle-aged and older obese subjects: a pilot study.  Journal of The American College of Nutrition. 2012;31(2):79-86.
  101. Prado CM, Lieffers JR, Bergsten G, Mourtzakis M, Baracos V, McCargar LJ. Dietary patterns of patients with advanced lung or colorectal cancerCanadian Journal of Dietetic Practice and Research. 2012;73(4):e298-303.
  102. Prado CM, Bekaii-Saab T, Doyle LA, Shrestha S, Ghosh S, Baracos VE, Sawyer MB. Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor - selemetunib in patients with cholangiocarcinoma. The British Journal of Cancer. 2012;106(10):1583-6.
  103. Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, Bain VG, Sawyer MB. Muscle wasting is associated with mortality in patients with cirrhosis. Clinical Gastroenterology and Hepatology. 2012;10(2):166-73. 
  104. Stretch C, Eastman T, Mandal R, Eisner R, Wishart DS, Mourtzakis M, Prado CMM, Damaraju S, Ball RO, Greiner R, Baracos VE. Prediction of skeletal muscle and fat mass in patients with advanced cancer using a metabolomic approach. The Journal of Nutrition. 2012;142(1):14-21.
  105. Prado CMM, Antoun S, Sawyer MB, Baracos VE. Two faces of drug therapy in cancer: drug-related lean tissue loss and its adverse consequences to survival and toxicity. Current Opinion in Nutrition & Metabolic Care. 2011;14(3):250-4.
  106. Prado CM, Lima IS, Baracos VE, Bies RR, McCargar LJ, Reiman T, Mackey JR, Kuzma M, Damaraju VL, Sawyer MB, An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity. Cancer Chemotherapy and Pharmacology.  2011;67(1):93-101.
  107. Prado CM, Mourtzakis M, Baracos VE, Reiman T, Sawyer MB, McCargar LJ. Overweight and obese patients with solid tumors may have sarcopenia, poor prognosis and early features of cachexia. International Journal of Body Composition. 2010;8(1):7-15.
  108. Prado CM, Birdsell LA, Baracos VE. The emerging role of computerized tomography in assessing cancer cachexia. Current Opinion in Supportive and Palliative Care. 2009;3:269-275.
  109. Prado CM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, Tonkin K, Mackey JR, Koski S, Pituskin E, Sawyer MB. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clinical Cancer Research. 2009;15(8):2920-6.
  110. Lieffers JR, Mourtzakis M, Hall KD, McCargar LJ, Prado CM, Baracos VE. A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands. The American Journal of Clinical Nutrition. 2009;89(4):1173-9.
  111. Mourtzakis M, Prado CM, Reiman T, McCargar LJ, and Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Applied Physiology, Nutrition and Metabolism. 2008;33(5):997-1006.
  112. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, and Baracos VE. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncology. 2008;9(7):629-35.
  113. Prado CM, Baracos VE, McCargar LJ, Mourtzakis M, Mulder KE, Reiman T, Butts, CA, Scarfe AG, Sawyer MB. Body Composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clinical Cancer Research. 2007;13(11):3264-8.
  114. Naves MMV, Fernandes DC, Prado CM, Teixeira LSM. Food fortification with egg shell powder as a calcium source. Ciencia e Tecnologia de Alimentos. 2007; 27:99-103 (Manuscript in Portuguese).
  115. Naves MMV, Prado CM, Fernandes DC, Serafini AB. Microbiological evaluation of egg shell powder and optimization of its preparation technique. Pesquisa Agropecuaria Tropical. 2007; 37:113-118 (Manuscript in Portuguese).
  116. Machado DC, Maia CM, Carvalho ID, Silva NF, Andres MCPB, Serafini AB. Microbiological quality of organic vegetables produced in soil treated with different types of manure and mineral fertilizer. Brazilian Journal of Microbiology. 2006; 37:538-544.  
Book Chapters:
Barbosa-Silva TG, Prado CM. The Role of Imaging Techniques in the Diagnosis of Sarcopenia and Sarcopenic Obesity. In: Sarcopenia: molecular and cellular aspects – applications to humans. Ed. Dominique Meunial-Denis, CRC Press New York, USA. Submitted.
Barrére AP, Pereira A, Prado C, Koch C. Composicao corporal em oncologia. In: Guia Nutricional de Oncologia. Edited by: Barrére AP, Pereira A, Hamerschlak N, Piovacari Filho SMF. Editora Atheneu, Sao Paolo, SP, Brazil. Submitted
Prado CM, Pinto CL, Gonzalez CM. Heymsfield S. Techniques for Assessment of Body Composition in Health. Scientific American Nutrition Edited by: Robinson ML, Mogensen KM, Saltzman E. SA Nutrition. Submitted.
Gonzalez CM, Purcell S, Prado CM, Heymsfield S. Body Composition in Starvation and Disease. Scientific American Nutrition Edited by: Robinson ML, Mogensen KM, Saltzman E. SA Nutrition. Submitted.
Prado CM, Elliott SA, Mota JF. Nutritional status and assessment with advanced imaging techniques. Eds. Hickson M, Smith S. In: Advanced Nutrition & Dietetics in Nutrition Support, British Dietetic Association. 2018. John Wiley & Sons.
Gonzalez MC, Prado CM, Barbosa-Silva TG, Belarmino G, Pereira A, Horie LM, Hoffman DJ, Heymsfield SB, Waitzberg DL. Composição Corporal (Body Composition). Chapter 19. In: Nutrição Oral, Enteral e Parenteral na Prática Clínica- 5ed. Ed. Dan K Waitzberg. Book in Portuguese.
Siervo M, Prado CM. Nutritional assessment of the critically ill patient. In: Nutrition in Critical Care. Editors, Faber P, Siervo M, Cambridge University Press, Cambridge, UK, 2014, p.2-19. ISBN: 9781107669017.
Baracos VE, Prado CM, Antoun S, Gioulbasanis I. Assessment of nutritional status. In: Nutrition and the Cancer Patient, E Del Fabbro, V Baracos, W Demark-Wahnefried, T Bowling, J Hopkinson, E Bruera Editors, Oxford University Press, New York, USA, 2010, p. 19-36. ISBN: 9780199550197.